A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine (NCT06641466)
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, PARALLEL GROUP STUDY TO INVESTIGATE INTERMITTENT PREVENTION OF MENSTRUAL MIGRAINE WITH RIMEGEPANT COMPARED WITH PLACEBO IN WOMEN PARTICIPANTS 18 TO 45 YEARS OF AGE
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience menstrual migraine attacks.
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic Hospital — Phoenix, Arizona
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (123 Sites)
Showing the first 25 of 123 sites.
- Mayo Clinic Hospital — Phoenix, Arizona
- Mayo Clinic Specialty Building — Phoenix, Arizona
- Mayo Clinic Arizona — Scottsdale, Arizona
- Hope Clinical Research, Inc. — Canoga Park, California
- Axiom Research — Colton, California
- Diablo Clinical Research, Inc. — Walnut Creek, California
- VIN - Aventura — Aventura, Florida
- Velocity Clinical Research, Hallandale Beach — Hallandale, Florida
- Jacksonville Center for Clinical Research — Jacksonville, Florida
- Urban Family Practice Associates — Marietta, Georgia
- Clinical Research Atlanta — Stockbridge, Georgia
- St Luke's Clinic - Neurology — Meridian, Idaho
- Alliance for Multispecialty Research - Medisphere Medical Research Center — Evansville, Indiana
- Michigan Headache & Neurological Institute — Ann Arbor, Michigan
- Clinvest Headlands Llc — Springfield, Missouri
- St. Charles Clinical Research — Weldon Spring, Missouri
- McGill Family Practice — Papillion, Nebraska
- Excel Clinical Research, LLC — Las Vegas, Nevada
- Rochester Clinical Research — Rochester, New York
- Montefiore Medical Center — The Bronx, New York
- Carolina Women's Research and Wellness Center — Durham, North Carolina
- Dayton Center for Neurological Disorders — Centerville, Ohio
- Thomas Jefferson University, Jefferson Headache Center — Philadelphia, Pennsylvania
- Clinical Research of Philadelphia — Philadelphia, Pennsylvania
- Velocity Clinical Research, Providence — East Greenwich, Rhode Island
📞 Contact the Study Coordinator
Phone: (800) 718-1021
Email: ClinicalTrials.gov_Inquiries@pfizer.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Menstrual Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.